Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-24-034071
Filing Date
2024-02-13
Accepted
2024-02-13 18:40:57
Documents
2
Group Members
CHRISTOPHER HOLLOWOODROEL BULTHUISSYNCONA HOLDINGS LTDSYNCONA INVESTMENT MANAGEMENT LTDSYNCONA LTD

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d782156dsc13ga.htm SC 13G/A 126039
2 EX-99.1 d782156dex991.htm EX-99.1 7192
  Complete submission text file 0001193125-24-034071.txt   135162
Mailing Address FRANCES HOUSE, PO BOX 273 SIR WILLIAM PLACE ST PETER PORT, GUERNSEY X0 GY1 3 RD
Business Address 3RD FLOOR, ARNOLD HOUSE PO BOX 273, ST JULIAN'S AVENUE ST PETER PORT Y7 GY1 3RD 001442039817909
Syncona Portfolio Ltd (Filed by) CIK: 0001725042 (see all company filings)

EIN.: 000000000 | State of Incorp.: Y7 | Fiscal Year End: 0331
Type: SC 13G/A

Mailing Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW
Business Address 245 HAMMERSMITH ROAD LONDON X0 W6 8PW 44 (0)20 8154 4600
Achilles Therapeutics plc (Subject) CIK: 0001830749 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92487 | Film No.: 24630833
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)